ReachMD
Be part of the knowledge.™
Popular
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC Action CenterNo effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
The Network Effect: Analyzing Brain Structures to Treat Depression
Medical Industry FeatureThe Network Effect: Analyzing Brain Structures to Treat Depression
The Dynamic Practice: Exploring Locum Tenens Opportunities
Spotlight on Locum TenensThe Dynamic Practice: Exploring Locum Tenens Opportunities
Deep Learner: Building AI to Improve Cardiovascular Care
Medical Industry FeatureDeep Learner: Building AI to Improve Cardiovascular Care
Severe Asthma: An Exploratory Study on Mucus Plugging
Medical Industry FeatureSevere Asthma: An Exploratory Study on Mucus Plugging
Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
CME/CEPruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
0.25 credits
Programs
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
MinuteCE®What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
1.00 program creditsSevere Asthma: An Exploratory Study on Mucus Plugging
Medical Industry FeatureSevere Asthma: An Exploratory Study on Mucus Plugging
Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
Medical Industry FeatureInflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
Delivering Transformation: Reducing Maternal Mortality Through Systemic Change
Medical Industry FeatureDelivering Transformation: Reducing Maternal Mortality Through Systemic Change
Addressing Treatment Gaps Among Patients with MDS-Associated Anemia
Medical Industry FeatureAddressing Treatment Gaps Among Patients with MDS-Associated Anemia
Mechanism of Disease: Immunoglobulin A Nephropathy
Medical Industry FeatureMechanism of Disease: Immunoglobulin A Nephropathy
Clinical Practice
The Gene Messenger: Advancing Neurological Gene Therapy
Medical Industry FeatureThe Gene Messenger: Advancing Neurological Gene Therapy
Deep Learner: Building AI to Improve Cardiovascular Care
Medical Industry FeatureDeep Learner: Building AI to Improve Cardiovascular Care
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
CME/CEPruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
0.25 creditsManaging AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
Clinician's RoundtableManaging AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
South Asians With IBD: Underrepresented and Underappreciated
CME/CESouth Asians With IBD: Underrepresented and Underappreciated
0.25 credits
Doctors Lounge
Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
CME/CELet’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
0.25 creditsRecognizing and Addressing Medical Gaslighting in Healthcare
NeuroFrontiersRecognizing and Addressing Medical Gaslighting in Healthcare
Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden
Project Oncology®Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden
25 Must-Know Medical Abbreviations
Brain Games25 Must-Know Medical Abbreviations
Preventing HIV & Substance Use in Incarcerated Women: Can an App Help?
Clinician's RoundtablePreventing HIV & Substance Use in Incarcerated Women: Can an App Help?
Op-Ed: The Growing Issue of Drug Shortages
Op-EdOp-Ed: The Growing Issue of Drug Shortages
CME
Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
CME/CEMaking the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
0.25 creditsNavigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM
CME/CE Live BroadcastApril 29, 2024
09:00 PM - 10:30 PM ET
Navigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM
Understanding the Recent Advances in IgAN
CME/CEUnderstanding the Recent Advances in IgAN
0.25 creditsExtending Treatment Durability With Next-Generation Neovascular AMD Therapies
CME/CEExtending Treatment Durability With Next-Generation Neovascular AMD Therapies
0.50 credits- CME/CE Meeting
May 25, 2024
13:45 - 14:45 CEST
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
- CME/CE Meeting
April 29, 2024
05:30 PM - 07:30 PM PST
Navigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM
Industry Feature
The Current Standard of Care and Unmet Need in Anemia of CKD
Medical Industry FeatureThe Current Standard of Care and Unmet Need in Anemia of CKD
Prevalence and Burden of Anemia of CKD
Medical Industry FeaturePrevalence and Burden of Anemia of CKD
Empower Your Patients With a Seizure Action Plan
Medical Industry FeatureEmpower Your Patients With a Seizure Action Plan
Diving into a Treatment for Seizure Clusters Through Patient Case Studies
Medical Industry FeatureDiving into a Treatment for Seizure Clusters Through Patient Case Studies
An FDA-Approved Therapeutic Treatment Option for Polymyalgia Rheumatica
Broadcast ReplayAn FDA-Approved Therapeutic Treatment Option for Polymyalgia Rheumatica
Advances in Acute Seizure Treatment Options
Medical Industry FeatureAdvances in Acute Seizure Treatment Options
